0001213900-17-012230.txt : 20171116 0001213900-17-012230.hdr.sgml : 20171116 20171116163059 ACCESSION NUMBER: 0001213900-17-012230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171114 FILED AS OF DATE: 20171116 DATE AS OF CHANGE: 20171116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zarrabian Saiid CENTRAL INDEX KEY: 0001495521 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37823 FILM NUMBER: 171208347 MAIL ADDRESS: STREET 1: P.O. BOX 675765 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DelMar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001498382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990360497 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 720-999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 BUSINESS PHONE: (604) 629-5989 MAIL ADDRESS: STREET 1: SUITE 720-999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 FORMER COMPANY: FORMER CONFORMED NAME: Berry Only Inc. DATE OF NAME CHANGE: 20100805 4 1 f4111417zarrabian_delmar.xml OWNERSHIP DOCUMENT X0306 4 2017-11-14 0 0001498382 DelMar Pharmaceuticals, Inc. DMPI 0001495521 Zarrabian Saiid SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 BRITISH COLUMBIA, CANADA 1 1 0 0 Interim CEO Common Stock 2017-11-14 4 P 0 55000 0.82 A 55000 D Common Stock 2017-11-14 4 P 0 5900 0.84 A 5900 I By Child This transaction was executed in multiple trades at prices ranging from $0.8015 to $0.8385. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $0.8298 to $0.84. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Saiid Zarrabian 2017-11-15